The effect of PHR spray on patients with coronavirus-19

Phase 2

• Conditions: COVID-19.; U07.2COVID-19, virus not identified, COVID-19; U07.2

• Registration Number: IRCT20160131026298N2
• Lead Sponsor: Bagheiat-allah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

Male or female patients 18-65 years with COVID-19 confirmed by PCR (with mild involvement) - Ground glass view on CT scan - Arterial oxygen saturation less than 93% - Breathing more than 24 times per minute - At the Beginning onset of the disease - Negative pregnancy test in women - Completion of informed consent form by patient or supervisor

Exclusion Criteria

Oral ulcer or malignancy - history of pulmonary malignancy - history of asthma or COPD

Study & Design

• Study Type: interventional
• Study Design: Not specified